Atlas Trials

Study of the Effects of Cyclodynon on Reducing the Cumulative Risk of Breast Cancer Development in a Female Aged 40-52

Clinical trial NCT04498013 · UNKNOWN

Trial details

NCT number
NCT04498013
Sponsor
Dr. Struk Tetiana
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Mammographic Breast Density
Start date
2020-07-22
Primary completion
2022-04-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.